No headlines found.
No press releases found.
No news found.
Humacyte - Warrant trades on the stock market under the symbol HUMAW.
As of September 10, 2026, HUMAW stock price was flat at $0.00 with million shares trading.
HUMAW has a beta of -0.20, meaning it tends to be less sensitive to market movements. HUMAW has a correlation of 0.00 to the broad based SPY ETF.
HUMAW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, HUMAW traded as high as $3.47 and as low as $.00.
HUMAW has underperformed the market in the last year with a return of -99.5%, while the SPY ETF gained +17.8%. In the last 3 month period, HUMAW fell short of the market, returning -98.5%, while SPY returned +3.2%. However, in the most recent 2 weeks HUMAW has outperformed the stock market by returning 0.0%, while SPY returned -1.0%.
HUMAW support price is $.00 and resistance is $.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUMAW shares will trade within this expected range on the day.
